Health Services Research and Development Service Scientific Merit Review Board, Notice of Meeting, 8623 [2020-02992]

Download as PDF Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices Designated Federal Officer, Rehabilitation Research and Development Service, at Department of Veterans Affairs (10X2R), 810 Vermont Avenue NW, Washington, DC 20420, or email Tiffany.Asqueri@va.gov prior to the meeting. Those who plan to attend the open portion of the meeting must contact Ms. Asqueri at least five days before the meeting. For further information, please call Mrs. Asqueri at (202) 443–5757. Dated: February 11, 2020. Jelessa M. Burney, Federal Advisory Committee Management Officer. [FR Doc. 2020–02990 Filed 2–13–20; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS khammond on DSKJM1Z7X2PROD with NOTICES Health Services Research and Development Service Scientific Merit Review Board, Notice of Meeting The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act that a meeting of the Health Services Research and Development Service Scientific Merit Review Board will he held March 12, 2020, by teleconference. The meeting will begin at 11:45 a.m. and end at 1:00 p.m. EST. The meeting will be partially closed to the public from 12:00 p.m. to 1:00 p.m. EST for the discussion, examination, and reference to the research applications and scientific review. Discussions will involve reference to staff and consultant critiques of research proposals. Discussions will deal with scientific merit of each proposal and qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals. As provided by subsection 10(d) of Public Law 92–463, as amended by Public Law 94–409, closing the committee meeting is in accordance with Title 5 U.S.C. 552b(c)(6) and (9)(B). The objective of the Board is to provide for the fair and equitable selection of the most meritorious research projects for support by VA research funds and to offer advice for research program officials on program priorities and policies. The ultimate objective of the Board is to ensure the high quality and mission relevance of VA’s legislatively mandated Health VerDate Sep<11>2014 16:56 Feb 13, 2020 Jkt 250001 Services Research and Development program. Board members advise the Director, Health Services Research and Development Service and the Chief Research and Development Officer on the scientific and technical merit, the mission relevance, and the protection of human subjects of Health Services Research and Development proposals. The Board does not consider grants, contracts, or other forms of extramural research. Members of the public who wish to attend the open portion of the teleconference session from 11:45 a.m. to 12:00 p.m. EST may dial 1 (800) 767– 1750, participant code 66422. Written comments from the public must be sent to Liza Catucci, Designated Federal Officer, Health Services Research and Development Service, at Department of Veterans Affairs (10X2H), 810 Vermont Avenue NW, Washington, DC 20420, or email Liza.Catucci@va.gov prior to the meeting. Those who plan to attend the open portion of the meeting must contact Ms. Catucci at least five days before the meeting. For further information, please call Ms. Catucci at (202) 443–5797. Dated: February 11, 2020. Jelessa M. Burney, Federal Advisory Committee Management Officer. [FR Doc. 2020–02992 Filed 2–13–20; 8:45 am] BILLING CODE P DEPARTMENT OF VETERANS AFFAIRS [OMB Control No. 2900–0778] Agency Information Collection Activity Under OMB Review: Disability Benefits Questionnaire (Group 3) Veterans Benefits Administration, Department of Veterans Affairs ACTION: Notice. AGENCY: In compliance with the Paperwork Reduction Act (PRA) of 1995, this notice announces that the Veterans Benefits Administration, Department of Veterans Affairs, will submit the collection of information abstracted below to the Office of Management and Budget (OMB) for review and comment. The PRA submission describes the nature of the information collection and its expected cost and burden and it includes the actual data collection instrument. DATES: Comments must be submitted on or before March 16, 2020. SUMMARY: PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 8623 Submit written comments on the collection of information through www.Regulations.gov, or to Office of Information and Regulatory Affairs, Office of Management and Budget, Attn: VA Desk Officer; 725 17th St. NW, Washington, DC 20503 or sent through electronic mail to oira_submission@ omb.eop.gov. Please refer to ‘‘OMB Control No. 2900–0778’’ in any correspondence. FOR FURTHER INFORMATION CONTACT: Danny S. Green, Enterprise Records Service (005R1B), Department of Veterans Affairs, 811 Vermont Avenue NW, Washington, DC 20420, (202) 421– 1354 or email danny.green2@va.gov. Please refer to ‘‘OMB Control No. 2900– 0778’’ in any correspondence. SUPPLEMENTARY INFORMATION: Authority: 44 U.S.C. 3501–21. Title: Disability Benefits Questionnaire (Group 3). OMB Control Number: 2900–0778. Type of Review: Reinstatement of a currently approved collection. Abstract: VA Form 21–0960 series called Disability Benefits Questionnaire (Group 3) gathers necessary information from a claimant’s treating physician regarding the results of medical examinations. VA will gather medical information related to the claimant that is necessary to adjudicate the claim for VA disability benefits. The Disability Benefit Questionnaires (Group 3) is comprised of 17 forms. Each DBQ title includes the names of the specific disability for which it gathers information. VAF 21–0960C–5, Central Nervous System and Neuromuscular Diseases Disability Benefits Questionnaire, gathers information related to the claimant’s diagnosis of a central nervous system disease; VAF 21–0960C–8, Headaches (Including Migraine Headaches) Disability Benefits Questionnaire, gathers information related to the claimant’s diagnosis of headaches; VAF 21–0960C–9, Multiple Sclerosis (MS) Disability Benefits Questionnaire, gathers information related to the claimant’s diagnosis of multiple sclerosis; VAF 21–0960G–1, Esophageal Disorders (including GERD, Hiatal Hernia, and Other Esophageal Disorders) Disability Benefits Questionnaire, gathers information related to the claimant’s diagnosis of any esophageal disorders; VAF 21– 0960G–2, Gall Bladder and Pancreas Conditions Disability Benefits Questionnaire, gathers information related to the claimant’s diagnosis of any gall bladder and pancreas condition; VAF 21–0960G–3, Intestinal Conditions (Other than Surgical or Infectious) Including Irritable Bowel ADDRESSES: E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 85, Number 31 (Friday, February 14, 2020)]
[Notices]
[Page 8623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02992]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Health Services Research and Development Service Scientific Merit 
Review Board, Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act that a meeting of the Health Services 
Research and Development Service Scientific Merit Review Board will he 
held March 12, 2020, by teleconference. The meeting will begin at 11:45 
a.m. and end at 1:00 p.m. EST. The meeting will be partially closed to 
the public from 12:00 p.m. to 1:00 p.m. EST for the discussion, 
examination, and reference to the research applications and scientific 
review. Discussions will involve reference to staff and consultant 
critiques of research proposals. Discussions will deal with scientific 
merit of each proposal and qualifications of personnel conducting the 
studies, the disclosure of which would constitute a clearly unwarranted 
invasion of personal privacy. Additionally, premature disclosure of 
research information could significantly obstruct implementation of 
proposed agency action regarding the research proposals. As provided by 
subsection 10(d) of Public Law 92-463, as amended by Public Law 94-409, 
closing the committee meeting is in accordance with Title 5 U.S.C. 
552b(c)(6) and (9)(B).
    The objective of the Board is to provide for the fair and equitable 
selection of the most meritorious research projects for support by VA 
research funds and to offer advice for research program officials on 
program priorities and policies. The ultimate objective of the Board is 
to ensure the high quality and mission relevance of VA's legislatively 
mandated Health Services Research and Development program.
    Board members advise the Director, Health Services Research and 
Development Service and the Chief Research and Development Officer on 
the scientific and technical merit, the mission relevance, and the 
protection of human subjects of Health Services Research and 
Development proposals. The Board does not consider grants, contracts, 
or other forms of extramural research.
    Members of the public who wish to attend the open portion of the 
teleconference session from 11:45 a.m. to 12:00 p.m. EST may dial 1 
(800) 767-1750, participant code 66422. Written comments from the 
public must be sent to Liza Catucci, Designated Federal Officer, Health 
Services Research and Development Service, at Department of Veterans 
Affairs (10X2H), 810 Vermont Avenue NW, Washington, DC 20420, or email 
[email protected] prior to the meeting. Those who plan to attend the 
open portion of the meeting must contact Ms. Catucci at least five days 
before the meeting. For further information, please call Ms. Catucci at 
(202) 443-5797.

    Dated: February 11, 2020.
Jelessa M. Burney,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-02992 Filed 2-13-20; 8:45 am]
 BILLING CODE P